1-4 of 4
Shubhra Ghosh, MD
Close
Sort by
Journal Articles

Natural History of AML / MDS Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Using Reduced Intensity (RIC) Preparative Regimens.

Betul Oran, MD, Sergio Giralt, MD, Munir Shahjahan, MD, Athanasios Anagnostopoulos, MD, Daniel Couriel, MD, Partow Kebriaei, MD, Chitra Hosing, MD, Shubhra Ghosh, MD, Ernesto de Meis, MD, Michele Donato, MD, Touch Ativivas, MD, Antonio Carrasco-Yalan, MD, Richard Champlin, MD, Marcos de Lima, MD
Journal: Blood
Blood (2005) 106 (11): 2019.
https://doi.org/10.1182/blood.V106.11.2019.2019
Published: 2005
Journal Articles

Clinical, Prognostic and Therapeutic Implications in the Diagnosis of Grade I Acute Graft-Versus-Host Disease.

Rima M. Saliba, PhD, Marcos de Lima, MD, Chitra Hosing, MD, Issa F. Khouri, MD, Sergio Giralt, MD, Paolo Anderlini, MD, Shubhra Ghosh, MD, Kerry Mickler, RN, Cindy Ippoliti, PHARMD, Zuraima Caldera, MD, Yvonne Hsu, PAC, Joyce Neumann, APN, Richard Champlin, MD, Daniel R. Couriel, MD
Journal: Blood
Blood (2005) 106 (11): 1799.
https://doi.org/10.1182/blood.V106.11.1799.1799
Published: 2005
Journal Articles

Secondary Malignancy after Allogeneic Stem Cell Transplantation: Incidence and Risk Factors.

Chitra Hosing, MD, Rima M. Saliba, PhD, Marcos De Lima, MD, Sergio Giralt, MD, Shubhra Ghosh, MD, Yvonne Hsu, Paolo Anderlini, MD, Sharon R. Hymes, MD, Borje Andersson, MD, Issa F. Khouri, MD, Richard Champlin, MD, Daniel Couriel, MD
Journal: Blood
Blood (2005) 106 (11): 1123.
https://doi.org/10.1182/blood.V106.11.1123.1123
Published: 2005
Journal Articles

Hyperacute Graft-Versus-Host Disease: Analysis of Risk Factors, Clinical Manifestations and Outcomes.

Daniel R. Couriel, MD, Rima Saliba, PhD, Marcos J. de Lima, MD, Chitra Hosing, MD, Borje Andersson, MD, Jorge De Jesus, RN, Kerry Mickler, RN, Yvonne Hsu, PA, Elizabeth J. Shpall, MD, Shubhra Ghosh, MD, Richard Champlin, MD
Journal: Blood
Blood (2004) 104 (11): 734.
https://doi.org/10.1182/blood.V104.11.734.734
Published: 2004